Advertisement

Neurologic Emergencies

  • Amit SabnisEmail author
  • Jonathan L. Finlay
  • Sabine Mueller
Chapter
Part of the Pediatric Oncology book series (PEDIATRICO)

Abstract

Neurologic complications of cancer and cancer therapy are common and can arise rapidly in pediatric oncology patients. Some of these complications can present as emergent situations that require rapid diagnosis and treatment; familiarity with these conditions and a low index of suspicion are absolutely necessary in caring for such patients. The emergencies of spinal cord compression, acute alteration in mental status, increased intracranial pressure and stroke are addressed in this chapter. Specific attention is given to the acute neurotoxic effects of common chemotherapeutic agents. In addition to background regarding possible etiologies that are unique to the child with cancer, the evidence bases for diagnostic steps and management are discussed. This chapter provides the necessary framework to recognize potential neurologic emergencies in pediatric oncology patients and highlights when to utilize a multidisciplinary team approach including pediatric oncologists and neuro-oncologists, intensivists, neurologists, radiation oncologists, and neurosurgeons to provide optimal care.

Keywords

Acute Lymphoblastic Leukemia Cerebral Perfusion Pressure Cord Compression Hemorrhagic Stroke Malignant Peripheral Nerve Sheath Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abend NS, Beslow LA, Smith SE et al (2011) Seizures as a presenting symptom of acute arterial ischemic stroke in childhood. J Pediatr 159:479–483PubMedCentralPubMedGoogle Scholar
  2. Acquaviva A, Marconcini S, Municchi G et al (2003) Non-Hodgkin lymphoma in a child presenting with acute paraplegia: a case report. Pediatr Hematol Oncol 20:245–251PubMedGoogle Scholar
  3. Adrogue HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342:1581–1589PubMedGoogle Scholar
  4. Amlie-Lefond C, Chan AK, Kirton A et al (2009) Thrombolysis in acute childhood stroke: design and challenges of the thrombolysis in pediatric stroke clinical trial. Neuroepidemiology 32:279–286PubMedGoogle Scholar
  5. Andersen C, Jensen FT (1998) Differences in blood-tumour-barrier leakage of human intracranial tumours: quantitative monitoring of vasogenic oedema and its response to glucocorticoid treatment. Acta Neurochir (Wien) 140:919–924Google Scholar
  6. Angelini P, Plantaz D, De Bernardi B et al (2011) Late sequelae of symptomatic epidural compression in children with localized neuroblastoma. Pediatr Blood Cancer 57:473–480PubMedGoogle Scholar
  7. Athale UH, Chan AK (2003) Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res 111:125–131PubMedGoogle Scholar
  8. Baker WJ, Royer GL Jr, Weiss RB (1991) Cytarabine and neurologic toxicity. J Clin Oncol 9:679–693PubMedGoogle Scholar
  9. Benesch M, Weber-Mzell D, Gerber NU et al (2010) Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. J Neurosurg Pediatr 6:137–144PubMedGoogle Scholar
  10. Bertsch H, Rudoler S, Needle MN et al (1998) Emergent/urgent therapeutic irradiation in pediatric oncology: patterns of presentation, treatment, and outcome. Med Pediatr Oncol 30:101–105PubMedGoogle Scholar
  11. Beslow LA, Licht DJ, Smith SE et al (2010) Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke 41:313–318PubMedCentralPubMedGoogle Scholar
  12. Bigby M, Stern RS (1988) Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System. J Am Acad Dermatol 18:543–552PubMedGoogle Scholar
  13. Bitzer M, Topka H (1995) Progressive cerebral occlusive disease after radiation therapy. Stroke 26:131–136PubMedGoogle Scholar
  14. Bowers DC, McNeil DE, Liu Y et al (2005) Stroke as a late treatment effect of Hodgkin’s Disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol 23:6508–6515PubMedGoogle Scholar
  15. Bowers DC, Liu Y, Leisenring W et al (2006) Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24:5277–5282PubMedGoogle Scholar
  16. Chern JJ, Tubbs RS, Gordon AS et al (2012) Management of pediatric patients with pseudotumor cerebri. Childs Nerv Syst 28:575–578PubMedGoogle Scholar
  17. Children’s Oncology Group (CCG 09709), Villablanca JG, Krailo MD et al (2006) Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children’s Oncology Group (CCG 09709). J Clin Oncol 24:3423–3430Google Scholar
  18. Culley DJ, Berger MS, Shaw D et al (1994) An analysis of factors determining the need for ventriculoperitoneal shunts after posterior fossa tumor surgery in children. Neurosurgery 34:402407; discussion 407–408Google Scholar
  19. Daley MF, Partington MD, Kadan-Lottick N et al (2003) Primary epidural burkitt lymphoma in a child: case presentation and literature review. Pediatr Hematol Oncol 20:333–338PubMedGoogle Scholar
  20. David KA, Picus J (2005) Evaluating risk factors for the development of ifosfamide encephalopathy. Am J Clin Oncol 28:277–280PubMedGoogle Scholar
  21. De Bernardi B, Pianca C, Pistamiglio P et al (2001) Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases. J Clin Oncol 19:183–190PubMedGoogle Scholar
  22. de Laat P, Te Winkel ML, Devos AS et al (2011) Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol 22:472–478PubMedGoogle Scholar
  23. Dorresteijn LD, Kappelle AC, Boogerd W et al (2002) Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 20:282–288PubMedGoogle Scholar
  24. Dorresteijn LD, Kappelle AC, Scholz NM et al (2005) Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer 41:1026–1030PubMedGoogle Scholar
  25. Drachtman RA, Cole PD, Golden CB et al (2002) Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol 19:319–327PubMedGoogle Scholar
  26. Dufourg MN, Landman-Parker J, Auclerc MF et al (2007) Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children. Leukemia 21:238–247PubMedGoogle Scholar
  27. Dunton SF, Nitschke R, Spruce WE et al (1986) Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A Pediatric Oncology Group study. Cancer 57:1083–1088PubMedGoogle Scholar
  28. Duval M, Suciu S, Ferster A et al (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children’s Leukemia Group phase 3 trial. Blood 99:2734–2739PubMedGoogle Scholar
  29. Eisenberg HM, McComb JG, Lorenzo AV (1974) Cerebrospinal fluid overproduction and hydrocephalus associated with choroid plexus papilloma. J Neurosurg 40:381–385PubMedGoogle Scholar
  30. Engelmann KA, Jordan LC (2012) Outcome measures used in pediatric stroke studies: a systematic review. Arch Neurol 69:23–27PubMedCentralPubMedGoogle Scholar
  31. Fouladi M, Langston J, Mulhern R et al (2000) Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol 18:824–831PubMedGoogle Scholar
  32. Fullerton HJ, Wu YW, Sidney S et al (2007) Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 119:495–501PubMedGoogle Scholar
  33. George R, Jeba J, Ramkumar G et al (2008) Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database Syst Rev (4):CD006716Google Scholar
  34. Glantz MJ, LaFollette S, Jaeckle KA et al (1999) Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17:3110–3116PubMedGoogle Scholar
  35. Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893PubMedGoogle Scholar
  36. Goldsby RE, Liu Q, Nathan PC et al (2010) Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 28:324–331PubMedCentralPubMedGoogle Scholar
  37. Grace RF, Dahlberg SE, Neuberg D et al (2011) The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol 152:452–459PubMedGoogle Scholar
  38. Greenwood MJ, Dodds AJ, Garricik R et al (2003) Posterior leukoencephalopathy in association with the tumour lysis syndrome in acute lymphoblastic leukaemia–a case with clinicopathological correlation. Leuk Lymphoma 44:719–721PubMedGoogle Scholar
  39. Grill J, Couanet D, Cappelli C et al (1999) Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 45:393–396PubMedGoogle Scholar
  40. Gupta V, Srivastava A, Bhatia B (2009) Hodgkin disease with spinal cord compression. J Pediatr Hematol Oncol 31:771–773PubMedGoogle Scholar
  41. Guyatt G, Gutterman D, Baumann MH et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 129:174–181PubMedGoogle Scholar
  42. Haddy N, Mousannif A, Tukenova M et al (2011) Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality. Brain 134:1362–1367PubMedGoogle Scholar
  43. Hamadani M, Awan F (2006) Role of thiamine in managing ifosfamide-induced encephalopathy. J Oncol Pharm Pract 12:237–239PubMedGoogle Scholar
  44. Hardesty DA, Sanborn MR, Parker WE et al (2011) Perioperative seizure incidence and risk factors in 223 pediatric brain tumor patients without prior seizures. J Neurosurg Pediatr 7:609–615PubMedGoogle Scholar
  45. Hartman AL, Lunney KM, Serena JE (2009) Pediatric stroke: do clinical factors predict delays in presentation? J Pediatr 154:727–732PubMedCentralPubMedGoogle Scholar
  46. Hayes FA, Thompson EI, Hvizdala E et al (1984) Chemotherapy as an alternative to laminectomy and radiation in the management of epidural tumor. J Pediatr 104:221–224PubMedGoogle Scholar
  47. Herzig RH, Hines JD, Herzig GP et al (1987) Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol 5:927–932PubMedGoogle Scholar
  48. Hinchey J, Chaves C, Appignani B et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500PubMedGoogle Scholar
  49. Hoffman KE, Yock TI (2009) Radiation therapy for pediatric central nervous system tumors. J Child Neurol 24:1387–1396PubMedGoogle Scholar
  50. Hollander M, Bots ML, Del Sol AI et al (2002) Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation 105:2872–2877PubMedGoogle Scholar
  51. Holmes D, Vishnu P, Dorer RK et al (2012) All-trans retinoic acid-induced pseudotumor cerebri during induction therapy for acute promyelocytic leukemia: a case report and literature review. Case Rep Oncol Med 2012:313057PubMedCentralPubMedGoogle Scholar
  52. Huang EA, Feldman BJ, Schwartz ID et al (2006) Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr 148:128–131PubMedGoogle Scholar
  53. Huisman TA (2009) Pediatric tumors of the spine. Cancer Imaging 9:S45–S48PubMedCentralPubMedGoogle Scholar
  54. Inaba H, Khan RB, Laningham FH et al (2008) Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 19:178–184PubMedGoogle Scholar
  55. Isome K, Matsubara K, Taki T et al (2011) Spinal cord compression by epidural involvement over 21 vertebral levels in acute lymphoblastic leukemia. J Pediatr Hematol Oncol 33:153–157PubMedGoogle Scholar
  56. Kaal EC, Vecht CJ (2004) The management of brain edema in brain tumors. Curr Opin Oncol 16:593–600PubMedGoogle Scholar
  57. Kenz S, Haas CS, Werth SC et al (2011) High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH). Ann Oncol 22:2696PubMedGoogle Scholar
  58. Khanna S, Davis D, Peterson B et al (2000) Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med 28:1144–1151PubMedGoogle Scholar
  59. Khasraw M, Holodny A, Goldlust SA et al (2012) Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience. Ann Oncol 23:458–463PubMedGoogle Scholar
  60. Kikuchi A, Maeda M, Hanada R et al (2007) Moyamoya syndrome following childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 48:268–272PubMedGoogle Scholar
  61. Kirkpatrick JP, van der Kogel AJ, Schultheiss TE (2010) Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 76:S42–S49PubMedGoogle Scholar
  62. Kitchen L, Westmacott R, Friefeld S et al (2012) The pediatric stroke outcome measure: a validation and reliability study. Stroke 43:1602–1608PubMedGoogle Scholar
  63. Klein SL, Sanford RA, Muhlbauer MS (1991) Pediatric spinal epidural metastases. J Neurosurg 74:70–75PubMedGoogle Scholar
  64. Kupfer A, Aeschlimann C, Wermuth B et al (1994) Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 343:763–764PubMedGoogle Scholar
  65. Laitt RD, Chambers EJ, Goddard PR et al (1995) Magnetic resonance imaging and magnetic resonance angiography in long term survivors of acute lymphoblastic leukemia treated with cranial irradiation. Cancer 76:1846–1852PubMedGoogle Scholar
  66. Land VJ, Shuster JJ, Crist WM et al (1994) Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 12:1939–1945PubMedGoogle Scholar
  67. Leone G, Gugliotta L, Mazzucconi MG et al (1993) Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study. Thromb Haemost 69:12–15PubMedGoogle Scholar
  68. Lim YJ, Park EK, Koh HC et al (2010) Syndrome of inappropriate secretion of antidiuretic hormone as a leading cause of hyponatremia in children who underwent chemotherapy or stem cell transplantation. Pediatr Blood Cancer 54:734–737PubMedGoogle Scholar
  69. Lo WD (2011) Childhood hemorrhagic stroke: an important but understudied problem. J Child Neurol 26:1174–1185PubMedCentralPubMedGoogle Scholar
  70. Loblaw DA, Perry J, Chambers A, Laperriere NJ (2005) Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative’s Neuro-Oncology Disease Site Group. J Clin Oncol 23:2028–2037PubMedGoogle Scholar
  71. Lucchini G, Grioni D, Colombini A et al (2008) Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer 51:629–633PubMedGoogle Scholar
  72. Mackay MT, Monagle P (2008) Perinatal and early childhood stroke and thrombophilia. Pathology 40:116–123PubMedGoogle Scholar
  73. Mahoney DH Jr, Shuster JJ, Nitschke R et al (1998) Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy–a Pediatric Oncology Group study. J Clin Oncol 16:1712–1722PubMedGoogle Scholar
  74. Mantadakis E, Katragkou A, Papadaki E et al (2008) Spinal cord compression in an adolescent with relapsed B-precursor acute lymphoblastic leukemia and mental neuropathy. Int J Hematol 88:294–298PubMedGoogle Scholar
  75. Mattioli Belmonte M, Gugliotta L, Delvos U et al (1991) A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase. Haematologica 76:209–214PubMedGoogle Scholar
  76. McGlennan C, Ganesan V (2008) Delays in investigation and management of acute arterial ischaemic stroke in children. Dev Med Child Neurol 50:537–540PubMedGoogle Scholar
  77. McQuilten ZK, Barnes C, Zatta A et al (2012) Off-label use of recombinant factor VIIa in pediatric patients. Pediatrics 129:e1533–e1540PubMedGoogle Scholar
  78. Medina LS, Pinter JD, Zurakowski D et al (1997) Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging. Radiology 202:819–824PubMedGoogle Scholar
  79. Meeske KA, Siegel SE, Gilsanz V et al (2009) Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation. Pediatr Blood Cancer 53:615–621PubMedGoogle Scholar
  80. Messe SR, Sansing LH, Cucchiara BL et al (2009) Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care 11:38–44PubMedGoogle Scholar
  81. Mitchell L, Andrew M, Hanna K et al (2003) Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb Haemost 90:235–244PubMedGoogle Scholar
  82. Moritz ML, Ayus JC (2010) New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatr Nephrol 25:1225–1238PubMedCentralPubMedGoogle Scholar
  83. Morris EB, Laningham FH, Sandlund JT et al (2007) Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 48:152–159PubMedGoogle Scholar
  84. Neville BG, Wilson J (1970) Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J 3:554–556PubMedCentralPubMedGoogle Scholar
  85. Norman JK, Parke JT, Wilson DA et al (2007) Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 49:198–203PubMedGoogle Scholar
  86. O’Leary DH, Polak JF, Kronmal RA et al (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14–22PubMedGoogle Scholar
  87. Ogiwara H, Nordli DR, DiPatri AJ et al (2010) Pediatric epileptogenic gangliogliomas: seizure outcome and surgical results. J Neurosurg Pediatr 5:271–276PubMedGoogle Scholar
  88. Olcay L, Aribas BK, Gokce M (2009) A patient with acute myeloblastic leukemia who presented with conus medullaris syndrome and review of the literature. J Pediatr Hematol Oncol 31:440–447PubMedGoogle Scholar
  89. Omura M, Aida N, Sekido K et al (1997) Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 38:241–249PubMedGoogle Scholar
  90. Papadopoulos KP, Garvin JH, Fetell M et al (1998) High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults. Bone Marrow Transplant 22:661–667PubMedGoogle Scholar
  91. Parikh SN, Crawford AH (2003) Orthopaedic implications in the management of pediatric vertebral and spinal cord tumors: a retrospective review. Spine (Phila Pa 1976) 28:2390–2396Google Scholar
  92. Patchell RA, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366:643–648PubMedGoogle Scholar
  93. Patel PN (2006) Methylene blue for management of ifosfamide-induced encephalopathy. Ann Pharmacother 40:299–303PubMedGoogle Scholar
  94. Pelgrims J, De Vos F, Van den Brande J et al (2000) Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer 82:291–294PubMedCentralPubMedGoogle Scholar
  95. Pitfield AF, Carroll AB, Kissoon N (2012) Emergency management of increased intracranial pressure. Pediatr Emerg Care 28:200–204; quiz 205–207PubMedGoogle Scholar
  96. Pollono D, Tomarchia S, Drut R et al (2003) Spinal cord compression: a review of 70 pediatric patients. Pediatr Hematol Oncol 20:457–466PubMedGoogle Scholar
  97. Pratt CB, Green AA, Horowitz ME et al (1986) Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. J Clin Oncol 4:1253–1261PubMedGoogle Scholar
  98. Rades D, Huttenlocher S, Dunst J et al (2010) Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol 28:3597–3604PubMedGoogle Scholar
  99. Rafay MF, Pontigon AM, Chiang J et al (2009) Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke 40:58–64PubMedGoogle Scholar
  100. Raffini L (2008) Thrombophilia in children: who to test, how, when, and why? Hematology Am Soc Hematol Educ Program 228–235Google Scholar
  101. Reddick WE, Glass JO, Helton KJ et al (2005) Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR Am J Neuroradiol 26:1263–1269PubMedCentralPubMedGoogle Scholar
  102. Relling MV, Pui CH, Sandlund JT et al (2000) Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 356:285–290PubMedGoogle Scholar
  103. Riva-Cambrin J, Detsky AS, Lamberti-Pasculli M et al (2009) Predicting postresection hydrocephalus in pediatric patients with posterior fossa tumors. J Neurosurg Pediatr 3:378–385PubMedGoogle Scholar
  104. Rivkees SA (2008) Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: the common, uncommon, and misnamed. Curr Opin Pediatr 20:448–452PubMedGoogle Scholar
  105. Roach ES (2000) Etiology of stroke in children. Semin Pediatr Neurol 7:244–260PubMedGoogle Scholar
  106. Roach ES, Golomb MR, Adams R et al (2008) Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 39:2644–2691PubMedGoogle Scholar
  107. Rollins N, Winick N, Bash R et al (2004) Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 25:1688–1695PubMedGoogle Scholar
  108. Rubin EH, Andersen JW, Berg DT et al (1992) Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia. J Clin Oncol 10:948–953PubMedGoogle Scholar
  109. Rubnitz JE, Relling MV, Harrison PL et al (1998) Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia. Leukemia 12:1176–1181PubMedGoogle Scholar
  110. Ruggiero A, Rizzo D, Mastrangelo S et al (2010) Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: is it time to change treatment? Pediatr Blood Cancer 54:193–198PubMedGoogle Scholar
  111. Sandoval C, Kutscher M, Jayabose S et al (2003) Neurotoxicity of intrathecal methotrexate: MR imaging findings. AJNR Am J Neuroradiol 24:1887–1890PubMedGoogle Scholar
  112. Schwenn MR, Blattner SR, Lynch E et al (1991) HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt’s lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 9:133–138PubMedGoogle Scholar
  113. Seet RC, Rabinstein AA, Lindell PE et al (2011) Cerebrovascular events after bevacizumab treatment: an early and severe complication. Neurocrit Care 15:421–427PubMedGoogle Scholar
  114. Silverman LB, Supko JG, Stevenson KE et al (2010) Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Blood 115:1351–1353PubMedCentralPubMedGoogle Scholar
  115. Simon T, Niemann CA, Hero B et al (2012) Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastoma. Dev Med Child Neurol 54:347–352PubMedGoogle Scholar
  116. Singh S, Bohn D, Carlotti AP et al (2002) Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit Care Med 30:2575–2579PubMedGoogle Scholar
  117. Smith MA, Adamson PC, Balis FM et al (1992) Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer. J Clin Oncol 10:1666–1673PubMedGoogle Scholar
  118. Smith GA, Damon LE, Rugo HS et al (1997) High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol 15:833–839PubMedGoogle Scholar
  119. Sommers LM, Hawkins DS (1999) Meningitis in pediatric cancer patients: a review of forty cases from a single institution. Pediatr Infect Dis J 18:902–907PubMedGoogle Scholar
  120. Spiegel RJ, Cooper PR, Blum RH et al (1984) Treatment of massive intrathecal methotrexate overdose by ventriculolumbar perfusion. N Engl J Med 311:386–388PubMedGoogle Scholar
  121. Srinivasan J, Miller SP, Phan TG et al (2009) Delayed recognition of initial stroke in children: need for increased awareness. Pediatrics 124:e227–e234PubMedGoogle Scholar
  122. Sterns RH, Nigwekar SU, Hix JK (2009) The treatment of hyponatremia. Semin Nephrol 29:282–299PubMedGoogle Scholar
  123. Taugourdeau-Raymond S, Rouby F, Default A et al (2012) Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database. Eur J Clin Pharmacol 68:1103–1107PubMedGoogle Scholar
  124. Ullrich NJ, Robertson R, Kinnamon DD et al (2007) Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 68:932–938PubMedGoogle Scholar
  125. Vos J, Aarnoudse MW, Dijk F et al (1983) On the cellular origin and development of atheromatous plaques. A light and electron microscopic study of combined X-ray and hypercholesterolemia-induced atheromatosis in the carotid artery of the rabbit. Virchows Arch B Cell Pathol Incl Mol Pathol 43:1–16PubMedGoogle Scholar
  126. White RH (2003) The epidemiology of venous thromboembolism. Circulation 107:I4–I8PubMedGoogle Scholar
  127. Widemann BC, Balis FM, Shalabi A et al (2004) Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst 96:1557–1559PubMedGoogle Scholar
  128. Wilne S, Collier J, Kennedy C et al (2007) Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol 8:685–689PubMedGoogle Scholar
  129. Winick NJ, Bowman WP, Kamen BA et al (1992) Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 84:252–256PubMedGoogle Scholar
  130. Zimmer JA, Garg BP, Williams LS et al (2007) Age-related variation in presenting signs of childhood arterial ischemic stroke. Pediatr Neurol 37:171–175PubMedGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2015

Authors and Affiliations

  • Amit Sabnis
    • 1
    Email author
  • Jonathan L. Finlay
    • 2
  • Sabine Mueller
    • 3
  1. 1.Division of Hematology/Oncology, Department of PediatricsBenioff Children’s Hospital, University of California-San FranciscoSan FranciscoUSA
  2. 2.Department of Hematology/Oncology/BMTNationwide Children’s HospitalColumbusUSA
  3. 3.Division of Hematology/Oncology, Department of Pediatrics, Neurology and NeurosurgeryBenioff Children’s Hospital, University of California-San FranciscoSan FranciscoUSA

Personalised recommendations